Manchester Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11
Closed -$568 1336
2026
Q1
$568 Buy
11
+10
+1,000% +$700 ﹤0.01% 1220
2025
Q4
$93 Sell
1
-16
-94% -$1.53K ﹤0.01% 1337
2025
Q3
$1.26K Hold
17
﹤0.01% 1122
2025
Q2
$2.21K Sell
17
-10
-37% -$1.45K ﹤0.01% 993
2025
Q1
$4.3K Hold
27
﹤0.01% 921
2024
Q4
$5.01K Buy
27
+10
+59% +$1.94K ﹤0.01% 891
2024
Q3
$3.59K Hold
17
﹤0.01% 936
2024
Q2
$2.28K Hold
17
﹤0.01% 940
2024
Q1
$3.65K Hold
17
﹤0.01% 775
2023
Q4
$3.46K Hold
17
﹤0.01% 750
2023
Q3
$3.37K Hold
17
﹤0.01% 702
2023
Q2
$5.52K Buy
17
+1
+6% +$286 ﹤0.01% 607
2023
Q1
$3.75K Hold
16
﹤0.01% 664
2022
Q4
$4.03K Hold
16
﹤0.01% 566
2022
Q3
$3K Sell
16
-40
-71% -$8.04K ﹤0.01% 583
2022
Q2
$10K Hold
56
﹤0.01% 488
2022
Q1
$14K Sell
56
-39
-41% -$8.91K ﹤0.01% 506
2021
Q4
$22K Hold
95
﹤0.01% 472
2021
Q3
$22K Buy
95
+79
+494% +$16.5K ﹤0.01% 506
2021
Q2
$3K Buy
+16
New +$3.17K ﹤0.01% 633

Other funds holding INSP

Manchester Capital Management's INSP Position: Q2 2026 in Review

Manchester Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 11 shares — an estimated $568 sold.

Manchester Capital Management first reported a position in INSP in Q2 2021 and held it in 20 quarters. The position peaked at $22K in Q4 2021. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Manchester Capital Management reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Manchester Capital Management sold 11 Inspire Medical Systems shares in Q2 2026, an estimated $568.
  • Manchester Capital Management first reported a position in Inspire Medical Systems in Q2 2021 and held it in 20 quarters.
  • Manchester Capital Management's Inspire Medical Systems position peaked at $22K in Q4 2021.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.